RECRUITING

Long COVID Cutaneous Signatures: An ARPA Funded Research Project

Description

This is a prospective, longitudinal study involving 300 participants for a single visit to compare Long COVID neurocutaneous biosignatures with those of other disorders affecting the sensory and autonomic nervous system.

Conditions

Long COVIDAcute COVID-19Postural Orthostatic Tachycardia Syndrome (POTS)Diabetic Neuropathy
Talk to us

Related Conditions:

Long COVIDAcute COVID-19Postural Orthostatic Tachycardia Syndrome (POTS)Diabetic Neuropathy

Study Overview

On this page

Study Details

Study overview

This is a prospective, longitudinal study involving 300 participants for a single visit to compare Long COVID neurocutaneous biosignatures with those of other disorders affecting the sensory and autonomic nervous system.

Long COVID Cutaneous Signatures: An ARPA Funded Research Project

Long COVID Cutaneous Signatures: An ARPA Funded Research Project

Condition
Long COVID
Intervention / Treatment

-

Contacts and Locations

Scottsdale

CND Life Sciences, Scottsdale, Arizona, United States, 85258

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Long COVID defined by NIH PASC criteria OR 2. Acute COVID who tested positive for COVID without persistent symptoms OR 3. Postural orthostatic tachycardia syndrome (POTS) OR 4. Diabetic neuropathy
  • 1. Clinical evidence of severe peripheral vascular disease 2. History of ulceration, poor wound healing or vascular claudication 3. History of allergic reaction to local anesthesia (for biopsy collection) 4. Use of oral anticoagulants (aspirin or Plavix alone is allowed) 5. History of a bleeding disorder

Ages Eligible for Study

18 Years to 80 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

CND Life Sciences,

Study Record Dates

2025-12-31